Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Haematologica|April 24, 2025
The specific transcriptional profile and clonal selection of monoclonal gammopathy of undetermined significance-like behavior predict an exceptionally favorable prognosis in multiple myelomaWenqiang Yan, Chen Qiu, Jieqiong Zhou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2026
Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001)Wenqiang Yan, Chenxing Du, Rui Lv, et al.
Leukemia|August 2, 2024
Clinical implications of residual normal plasma cells within bone marrow across various disease stages in multiple myelomaWenqiang Yan, Lihui Shi, Jingyu Xu, et al.
Ebiomedicine|March 28, 2022
Indirubin-3'-monoxime acts as proteasome inhibitor: Therapeutic application in multiple myelomaZhen Yu, Xiaojing Wei, Lanting Liu, et al.
Molecular Cancer Research : MCR|April 22, 2020
Polycomb-like Protein 3 Induces Proliferation and Drug Resistance in Multiple Myeloma and Is Regulated by miRNA-15aTengteng Yu, Chenxing Du, Xiaoke Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2024
Identification of Therapy-Induced Clonal Evolution and Resistance Pathways in Minimal Residual Clones in Multiple Myeloma through Single-Cell SequencingJian Cui, Xiaoyun Li, Shuhui Deng, et al.
Journal of Medicinal Chemistry|February 24, 2023
Development of a Covalent Inhibitor of c-Jun N-Terminal Protein Kinase (JNK) 2/3 with Selectivity over JNK1Wenchao Lu, Yao Liu, Yang Gao, et al.
Blood Cancer Journal|November 5, 2020
VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivoTengteng Yu, Bharat Chaganty, Liang Lin, et al.
Signal Transduction and Targeted Therapy|March 12, 2025
Thalidomide-based regimen shows promising efficacy in large granular lymphocytic leukemia: a multicenter phase II studyYing Yu, Yuxi Li, Rui Cui, et al.
Blood|March 19, 2020
YWHAE/14-3-3ε expression impacts the protein load, contributing to proteasome inhibitor sensitivity in multiple myelomaYan Xu, Mariateresa Fulciniti, Mehmet K Samur, et al.
Pageof 3